Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Saxagliptin, alogliptin, and cardiovascular outcomes.

× No keyword cloud information.

7 in total

Review 1. Cardiovascular effects of incretin therapy in diabetes care.

Authors: Jongoh Kim; Susan L Samson
Journal: Metab Syndr Relat Disord Date: 2014-05-19 Impact factor: 1.894

Review 2. Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials.

Authors: George Grunberger
Journal: Eur J Clin Pharmacol Date: 2014-09-02 Impact factor: 2.953

Review 3. Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials.

Authors: Jixin Zhong; Quan Gong; Aditya Goud; Srividya Srinivasamaharaj; Sanjay Rajagopalan
Journal: J Diabetes Res Date: 2015-05-14 Impact factor: 4.011

Review 4. Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?

Authors: Wellington Santana da Silva Júnior; Amélio Fernando de Godoy-Matos; Luiz Guilherme Kraemer-Aguiar
Journal: Biomed Res Int Date: 2015-06-04 Impact factor: 3.411

Review 5. Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure.

Authors: Thiago A Salles; Leonardo dos Santos; Valério G Barauna; Adriana C C Girardi
Journal: Int J Mol Sci Date: 2015-02-16 Impact factor: 5.923

Review 6. Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis.

Authors: Hung-Wei Liao; Jeffrey L Saver; Yi-Ling Wu; Tso-Hsiao Chen; Meng Lee; Bruce Ovbiagele
Journal: BMJ Open Date: 2017-01-05 Impact factor: 2.692

Review 7. Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy.

Authors: Oliver J Ziff; Daniel I Bromage; Derek M Yellon; Sean M Davidson
Journal: Cardiovasc Res Date: 2018-03-01 Impact factor: 10.787

7 in total